About ViaCord
Since 1993, ViaCord's dedication to care, and attention to every detail, has made us a leader in cord blood preservation. Both ViaCord and PerkinElmer, our parent company, share the same goal - to help save lives. As the world's leading provider of neonatal screening systems, PerkinElmer has helped to identify more than 100,000 newborns at risk of inherited metabolic disorders. ViaCord offers expecting families the unique combination of cord blood expertise and the piece of mind that comes with PerkinElmer's strength and stability.
About PerkinElmer
PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and their environment. The Company reported revenue of $1.8 billion in 2007, has approximately 9,100 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.
At PerkinElmer, we’re taking action to create a better tomorrow. Engaged in a proactive fight against illness, contamination and threats to our well-being, PerkinElmer conceives and delivers scientific solutions and components to meet our society’s ever-changing needs. We’re committed to transforming risk into safety, mystery into knowledge, and ideas into action for a healthy, clean, and safe tomorrow.